1. S43 Results from the STAR-COVID19 trial, a double-blind RCT of stabilised, synthetic sulforaphane in hospitalised patients with suspected COVID19. (11th November 2022) Authors: Long, MB; Abo-Leyah, H; Giam, YH; Vadiveloo, T; Hull, RC; Keir, HR; Pembridge, T; Alferes de Lima, D; New, BJM; Inglis, S; Gilmour, A; Hughes, C; Delgado, L; MacLennan, G; Dinkova-Kostova, AT; Chalmers, JD Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗